Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Inherit Metab Dis ; 44(6): 1330-1342, 2021 11.
Artículo en Inglés | MEDLINE | ID: mdl-34297429

RESUMEN

Propionic aciduria (PA) is caused by deficiency of the mitochondrial enzyme propionyl-CoA carboxylase (PCC). Due to inefficient propionate catabolism patients are endangered by life-threatening ketoacidotic crisis. Protein and amino acid restriction are major therapeutic pillars. However, long-term complications like neurological deterioration and cardiac abnormalities cannot be prevented. Chronic kidney disease (CKD), which is a well-known characteristic of methylmalonic aciduria two enzymatic steps downstream from PCC, has been recognized as a novel late-onset complication in PA. The pathophysiology of CKD in PA is unclear. We investigated mitochondrial structure and metabolism in human renal tubular cells of healthy controls and PA patients. The cells were exposed to either standard cell culture conditions (NT), high protein (HP) or high concentrations of isoleucine and valine (I/V). Mitochondrial morphology changed to condensed, fractured morphology in PA cells irrespective of the cell culture medium. HP and I/V exposure, however, potentiated oxidative stress in PA cells. Mitochondrial mass was enriched in PA cells, and further increased by HP and I/V exposure suggesting a need for compensation. Alterations in the tricarboxylic acid cycle intermediates and accumulation of medium- and long-chain acylcarnitines pointed to altered mitochondrial energy metabolism. Mitophagy was silenced while autophagy as cellular defense mechanisms was highly active in PA cells. The data demonstrate that PA is associated with renal mitochondrial damage which is aggravated by protein and I/V load. Preservation of mitochondrial energy homeostasis in renal cells may be a potential future therapeutic target.


Asunto(s)
Errores Innatos del Metabolismo de los Aminoácidos/patología , Metilmalonil-CoA Descarboxilasa/genética , Mitocondrias/metabolismo , Acidemia Propiónica/genética , Insuficiencia Renal Crónica/patología , Errores Innatos del Metabolismo de los Aminoácidos/complicaciones , Estudios de Casos y Controles , Línea Celular , Ciclo del Ácido Cítrico , Metabolismo Energético/genética , Células Epiteliales/metabolismo , Humanos , Metilmalonil-CoA Descarboxilasa/metabolismo , Mitocondrias/patología , Estrés Oxidativo/genética , Acidemia Propiónica/enzimología , Insuficiencia Renal Crónica/complicaciones
2.
J Inherit Metab Dis ; 44(4): 1039-1050, 2021 07.
Artículo en Inglés | MEDLINE | ID: mdl-33661535

RESUMEN

Fabry disease (FD) is an X-linked lysosomal storage disorder. Deficiency of the lysosomal enzyme alpha-galactosidase (GLA) leads to accumulation of potentially toxic globotriaosylceramide (Gb3) on a multisystem level. Cardiac and cerebrovascular abnormalities as well as progressive renal failure are severe, life-threatening long-term complications. The complete pathophysiology of chronic kidney disease (CKD) in FD and the role of tubular involvement for its progression are unclear. We established human renal tubular epithelial cell lines from the urine of male FD patients and male controls. The renal tubular system is rich in mitochondria and involved in transport processes at high-energy costs. Our studies revealed fragmented mitochondria with disrupted cristae structure in FD patient cells. Oxidative stress levels were elevated and oxidative phosphorylation was upregulated in FD pointing at enhanced energetic needs. Mitochondrial homeostasis and energy metabolism revealed major changes as evidenced by differences in mitochondrial number, energy production and fuel consumption. The changes were accompanied by activation of the autophagy machinery in FD. Sirtuin1, an important sensor of (renal) metabolic stress and modifier of different defense pathways, was highly expressed in FD. Our data show that lysosomal FD impairs mitochondrial function and results in severe disturbance of mitochondrial energy metabolism in renal cells. This insight on a tissue-specific level points to new therapeutic targets which might enhance treatment efficacy.


Asunto(s)
Enfermedad de Fabry/complicaciones , Insuficiencia Renal Crónica/etiología , Adolescente , Células Epiteliales/metabolismo , Enfermedad de Fabry/genética , Humanos , Lisosomas/metabolismo , Masculino , Mitocondrias/patología , Estrés Oxidativo/genética , Sistema de Registros , Insuficiencia Renal Crónica/genética , Trihexosilceramidas/sangre , Adulto Joven , alfa-Galactosidasa/sangre
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA